Sponsored by:

Molecular Imaging

ISMRM: Trimodal PET-MR-FUS may be feasible therapy monitoring option
By Amerigo Allegretto
Researchers at ISMRM 2025 touted the success of a trimodal MR-PET-FUS system that could have applications for therapy monitoring.
May 10, 2025
Researchers at ISMRM highlighted the success of a trimodal MR-PET-FUS system built around a low-field MRI scanner. MR (top) and PET (bottom) images were acquired simultaneously before and after FUS heating.
Beta-amyloid testing results have limited emotional impact for patients
By Maryam Payne
Receiving results from amyloid beta testing did not have a significant negative emotional impact on patients, whether negative or positive, findings from a new study show.
May 9, 2025
Brain Amyloid Plaque Neuron
PET/MRI reveals how brain stimulation technique works
By Will Morton
PET/MRI scans have revealed the mechanism underlying a brain stimulation technique for treating neurological and psychiatric conditions.
May 9, 2025
2025 05 09 Brain Stimulation Thumbnail
Whole-body PET shows how naloxone blocks opioids
By Will Morton
PET imaging has shown for the first time how the opioid overdose treatment naloxone blocks neuroreceptors throughout the body.
May 9, 2025
Naloxone2 Thumbnail
Shine to buy Lantheus’ SPECT business
By AuntMinnie.com staff writers
Medical isotope developer Shine Technologies has entered an agreement to acquire Lantheus Holdings’ SPECT business.
May 7, 2025
Acquisitions
Siemens posts strong revenue growth in Q2 2025
By AuntMinnie.com staff writers
Siemens Healthineers reported revenue growth in the second quarter of 2025 compared to last year.
May 7, 2025
Siemens2
SPECT/CT MPI may guide medical therapy in CAD patients
By Will Morton
SPECT/CT myocardial perfusion imaging can identify patients with coronary artery disease who are more likely to benefit from specific therapies.
May 7, 2025
Screenshot 2025 05 06 141932
FDA clears GE's new dual-head SPECT/CT system
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared GE HealthCare's (GEHC) new dual-head SPECT/CT system, Aurora.
May 5, 2025
Gehc
PET/MRI and DECT show abnormalities in long COVID patients
By Will Morton
Patients with long COVID show lung and heart abnormalities on PET/MRI and dual-energy CT imaging.
May 5, 2025
Myocardial involvement. Representative examples show fused PET/MRI images in patients with findings suggestive of myocarditis. (A and B) Short-axis view of increased F-18 FDG uptake in basal septum segments (A), colocalized with area of increased T2 values (B) on parametric mapping. (C and D) Prominent F-18 FDG uptake in middle anterolateral and inferolateral walls (C), matching area of increased T1 values (D). (E and F) Short-axis views of avid F-18 FDG uptake in basal inferior and inferolateral walls (E), matching areas of increased extracellular volume (F). SUV scale is 0-5 g/mL.
IMV: PET/CT service contracts are a key aspect of system ownership
By Davin Korstjens
Davin Korstjens of IMV Medical Information Division discusses the newly published IMV 2025 PET Market Summary Report.
May 2, 2025
Cardiac Pet
Controversy clouds nuclear medicine bill
By Will Morton
Radiology societies and patient advocates are at odds over a bill in the U.S. Congress.
May 1, 2025
Congress
FDA rejects NDA for Telix’s Pixclara
By AuntMinnie.com staff writers
The FDA has ruled that Telix's New Drug Application (NDA) for TLX101-CDx (Pixclara) cannot be approved in its current form.
April 29, 2025
Glioma Letters Brain
Page 1 of 604
Next Page